Complete ICD-10-CM coding and documentation guide for Uterine Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Uterine Cancer
Malignant neoplasms of the uterus
This range includes specific codes for different parts of the uterus, such as the endometrium and myometrium, as well as unspecified sites.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C54.1 | Malignant neoplasm of endometrium | Use when biopsy confirms endometrial adenocarcinoma. |
|
C54.2 | Malignant neoplasm of myometrium | Use when biopsy confirms myometrial sarcoma. |
|
C55 | Malignant neoplasm of uterus, part unspecified | Use when the specific site within the uterus cannot be determined. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Uterine Cancer
Use when biopsy confirms myometrial sarcoma.
Ensure myometrial origin is confirmed.
Use when the specific site within the uterus cannot be determined.
Use only when specific site cannot be determined.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Secondary malignant neoplasm of retroperitoneum and peritoneum
C78.6Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Uterine Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C54.1.
Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denial.
Verify histology before coding, Use N85.02 for hyperplasia without atypia
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data representation in patient records.
Code C54.1 if biopsy confirms endometrial origin, even if staging is pending.
Lack of specific histology documentation can lead to coding errors.
Ensure biopsy results are documented and reviewed before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Uterine Cancer, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Uterine Cancer. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Uterine Cancer? Ask your questions below.